Plunkett Research Online: Neurogene Inc

NEUROGENE INC (NGNE:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated pr.....



Neurogene Inc
Ticker: NGNE
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 732-2133
Fax: 778 331-4486
Address: 535 W 24th Street
5th Floor
New York, NY 10011 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmacies and Drug Stores
Contacts Description
Rachel McMinnCEO/Chairman of the Board/Director/Founder
Christine CvijicCFO/Chief Accounting Officer/President
See More
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated pr.....See More See More

Auditor: DELOITTE & TOUCHE LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2024202320222021
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: